HPLC-ESI-MS (large molecules)

Characterization of large molecules (e.g. monoclonal antibodies & antibody drug conjugates)

Therapeutic Modalities:

Biologics, Cell & Gene Therapies

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.2.43, USP <736>